Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Theravance Bio Ord (NQ: TBPH )

10.58 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 10.58
Bid (Size) 9.500 (2)
Ask (Size) 11.77 (1)
Prev. Close 10.58
Today's Range 10.58 - 10.58
52wk Range 7.530 - 11.83
Shares Outstanding 62,864,474
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Theravance Biopharma Finally Shelves Failed JAK Inhibitor Program, Lays Off Staff
 
Via Benzinga
Irenic Sends Letter to Theravance Biopharma Regarding the Urgent Need for a Governance Overhaul, Capital Return and Strategic Review
From Irenic Capital Management, LP
Via Business Wire

Performance

YTD
-3.56%
-3.56%
1 Month
+0.19%
+0.19%
3 Month
-4.08%
-4.08%
6 Month
+5.59%
+5.59%
1 Year
+10.55%
+10.55%

More News

Read More
Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings
Via Benzinga
A Preview Of Theravance Biopharma's Earnings
Via Benzinga
Here's Why Theravance Biopharma Shares Are Moving
Via Benzinga
Earnings Scheduled For February 27, 2023
Via Benzinga
Earnings Preview: Theravance Biopharma
Via Benzinga
Earnings Scheduled For November 7, 2022
Via Benzinga
Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings
Via Benzinga
Looking Into Theravance Biopharma's Return On Capital Employed
Via Benzinga
Theravance Biopharma's Earnings: A Preview
Via Benzinga
Why Is Conagra Brands Dropping By More Than 8%? 43 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Is Ericsson Down By 9%? 22 Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Via Benzinga
Theravance Biopharma's Earnings Outlook
Via Benzinga
Theravance Biopharma's Ampreloxetine Shows Benefit In Atrophy Patients, But Not In Parkinson's
Via Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Via Benzinga
Why Theravance Biopharma Stock Is Trading Lower After Hours
Via Benzinga
World Markets News For Friday
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.